Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma

American Journal of Pathology

Volumn 184, Issue 1, 2014, Pages 282-295

  Gravelle, Pauline ^a,b,c,d,e   Jean, Christine ^a,b,c   Familiades, Julien ^a,b,c,d,e   Decaup, Emilie ^a,b,c,d,e,f   Blanc, Amandine ^a,b,c,d,e   Bezombes Cagnac, Christine ^a,b,c,d,e   Laurent, Camille ^b,g,h   Savina, Ariel ^f   Fournié, Jean Jacques ^a,b,c,d,e   Laurent, Guy ^a,b,c,d,e,h  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c CANCER RESEARCH CENTER OF TOULOUSE   (France)

^d Institut Carnot Lymphome CALYM   (France)

^e Laboratoire d'Excellence Toulouse Cancer TOUCAN   (France)

^f Roche   (France)

^g INSERM   (France)

^h CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENDAMUSTINE; CD24 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PIMONIDAZOLE; PROTEIN BNIP3; TRANSCRIPTOME;

ARTICLE; CELL AGGREGATION; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL SUBPOPULATION; CELL SURVIVAL; CELL SUSPENSION; CONTROLLED STUDY; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPHOMA CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; STAINING; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA, FOLLICULAR; TRANSCRIPTOME; TRANSDUCTION, GENETIC; TUMOR ESCAPE;

EID: 84890423102     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.09.018     Document Type: Article

References (45)

1. E. Leich, I. Salaverria, S. Bea, A. Zettl, G. Wright, V. Moreno, R.D. Gascoyne, W.C. Chan, R.M. Braziel, L.M. Rimsza, D.D. Weisenburger, J. Delabie, E.S. Jaffe, A. Lister, J. Fitzgibbon, L.M. Staudt, E.M. Hartmann, H.K. Mueller-Hermelink, E. Campo, G. Ott, and A. Rosenwald Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations Blood 114 2009 826 834
2. N. Masir, L.J. Campbell, L.K. Goff, M. Jones, T. Marafioti, J. Cordell, A.J. Clear, T.A. Lister, D.Y. Mason, and A.M. Lee BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations Br J Haematol 144 2009 716 725
3. B. Mayer, G. Klement, M. Kaneko, S. Man, S. Jothy, J. Rak, and R.S. Kerbel Multicellular gastric cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas Gastroenterology 121 2001 839 852
4. M. Zietarska, C.M. Maugard, A. Filali-Mouhim, M. Alam-Fahmy, P.N. Tonin, D.M. Provencher, and A.M. Mes-Masson Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC) Mol Carcinog 46 2007 872 885
5. M. Wartenberg, C. Frey, H. Diedershagen, J. Ritgen, J. Hescheler, and H. Sauer Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids Int J Cancer 75 1998 855 863
6. J. Overgaard Hypoxic radiosensitization: adored and ignored J Clin Oncol 25 2007 4066 4074
7. V. Dangles-Marie, S. Richon, M. El-Behi, H. Echchakir, G. Dorothée, J. Thiery, P. Validire, I. Vergnon, J. Menez, M. Ladjimi, S. Chouaib, D. Bellet, and F. Mami-Chouaib A three-dimensional tumor cell defect in activating autologous CTLs is associated with inefficient antigen presentation correlated with heat shock protein-70 down-regulation Cancer Res 63 2003 3682 3687
8. C. Feder-Mengus, S. Ghosh, W.P. Weber, S. Wyler, P. Zajac, L. Terracciano, D. Oertli, M. Heberer, I. Martin, G.C. Spagnoli, and A. Reschner Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes Br J Cancer 96 2007 1072 1082
9. S. Ghosh, R. Rosenthal, P. Zajac, W.P. Weber, D. Oertli, M. Heberer, I. Martin, G.C. Spagnoli, and A. Reschner Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen Ann Surg 242 2005 851 857 discussion 858
10. N.E. Timmins, and L.K. Nielsen Generation of multicellular tumor spheroids by the hanging-drop method Methods Mol Med 140 2007 141 151
11. H. Hernandez-Pigeon, C. Jean, A. Charruyer, M.J. Haure, M. Titeux, L. Tonasso, A. Quillet-Mary, C. Baudouin, M. Charveron, and G. Laurent Human keratinocytes acquire cellular cytotoxicity under UV-B irradiation. Implication of granzyme B and perforin J Biol Chem 281 2006 13525 13532
12. J. Méndez, and B. Stillman Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis Mol Cell Biol 20 2000 8602 8612
13. C.T. Jordan, G. Yamasaki, and D. Minamoto High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations Exp Hematol 24 1996 1347 1355
14. A. Gothot, R. Pyatt, J. McMahel, S. Rice, and E.F. Srour Assessment of proliferative and colony-forming capacity after successive in vitro divisions of single human CD34+ cells initially isolated in G0 Exp Hematol 26 1998 562 570
15. M. Compagno, W.K. Lim, A. Grunn, S.V. Nandula, M. Brahmachary, Q. Shen, F. Bertoni, M. Ponzoni, M. Scandurra, A. Califano, G. Bhagat, A. Chadburn, R. Dalla-Favera, and L. Pasqualucci Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma Nature 459 2009 717 721
16. F. Pont, M. Tosolini, B. Ycart, and J.J. Fournié H.C.E. Leung, nwCompare and AutoCompare softwares for proteomics and transcriptomics data mining - application to the exploration of gene expression profiles of aggressive lymphomas. Integrative Proteomics 2012 Tech Open Access Publisher http://dx.doi.org/10.5772/29555
17. F. Pont, and J.J. Fournié Sorting protein lists with nwCompare: a simple and fast algorithm for n-way comparison of proteomic data files Proteomics 10 2010 1091 1094
18. J.I. Bárdos, and M. Ashcroft Negative and positive regulation of HIF-1: a complex network Biochim Biophys Acta 1755 2005 107 120
19. J.A. Forsythe, B.H. Jiang, N.V. Iyer, F. Agani, S.W. Leung, R.D. Koos, and G.L. Semenza Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 Mol Cell Biol 16 1996 4604 4613
20. R.E. Davis, K.D. Brown, U. Siebenlist, and L.M. Staudt Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells J Exp Med 194 2001 1861 1874
21. C.D. Laherty, H.M. Hu, A.W. Opipari, F. Wang, and V.M. Dixit The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B J Biol Chem 267 1992 24157 24160
22. I. Guasparri, D. Bubman, and E. Cesarman EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression Blood 111 2008 3813 3820
23. K.A. Roebuck, and A. Finnegan Regulation of intercellular adhesion molecule-1 (CD54) gene expression J Leukoc Biol 66 1999 876 888
24. N. Rivard, G. L'Allemain, J. Bartek, and J. Pouysségur Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts J Biol Chem 271 1996 18337 18341
25. P. Perucca, O. Cazzalini, M. Madine, M. Savio, R.A. Laskey, V. Vannini, E. Prosperi, and L.A. Stivala Loss of p21 CDKN1A impairs entry to quiescence and activates a DNA damage response in normal fibroblasts induced to quiescence Cell Cycle 8 2009 105 114
26. A.V. Guitart, M. Hammoud, P. Dello Sbarba, Z. Ivanovic, and V. Praloran Slow-cycling/quiescence balance of hematopoietic stem cells is related to physiological gradient of oxygen Exp Hematol 38 2010 847 851
27. N. Goda, H.E. Ryan, B. Khadivi, W. McNulty, R.C. Rickert, and R.S. Johnson Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia Mol Cell Biol 23 2003 359 369
28. E.M. Nelson, K.M. Tewey, and L.F. Liu Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9- acridinylamino)-methanesulfon-m-anisidide Proc Natl Acad Sci U S A 81 1984 1361 1365
29. B. Weigelt, A.T. Lo, C.C. Park, J.W. Gray, and M.J. Bissell HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment Breast Cancer Res Treat 122 2010 35 43
30. E.K. Jeong, S.Y. Lee, H.M. Jeon, M.K. Ju, C.H. Kim, and H.S. Kang Role of extracellular signal-regulated kinase (ERK)1/2 in multicellular resistance to docetaxel in MCF-7 cells Int J Oncol 37 2010 655 661
31. H. Sauer, J. Ritgen, J. Hescheler, and M. Wartenberg Hypotonic Ca2+ signaling and volume regulation in proliferating and quiescent cells from multicellular spheroids J Cell Physiol 175 1998 129 140
32. H. Liu, A.S. Adler, E. Segal, and H.Y. Chang A transcriptional program mediating entry into cellular quiescence PLoS Genet 3 2007 e91
33. A. Sgambato, A. Cittadini, B. Faraglia, and I.B. Weinstein Multiple functions of p27(Kip1) and its alterations in tumor cells: a review J Cell Physiol 183 2000 18 27
34. S. Ezoe, I. Matsumura, Y. Satoh, H. Tanaka, and Y. Kanakura Cell cycle regulation in hematopoietic stem/progenitor cells Cell Cycle 3 2004 314 318
35. M.J. Tindall, L. Dyson, K. Smallbone, and P.K. Maini Modelling acidosis and the cell cycle in multicellular tumour spheroids J Theor Biol 298 2012 107 115
36. D.V. Labarbera, B.G. Reid, and B.H. Yoo The multicellular tumor spheroid model for high-throughput cancer drug discovery Expert Opin Drug Discov 7 2012 819 830
37. L.B. Gardner, Q. Li, M.S. Park, W.M. Flanagan, G.L. Semenza, and C.V. Dang Hypoxia inhibits G1/S transition through regulation of p27 expression J Biol Chem 276 2001 7919 7926
38. A.M. Evens, P.T. Schumacker, I.B. Helenowski, A.T. Singh, D. Dokic, A. Keswani, E. Kordeluk, A. Raji, J.N. Winter, B.D. Jovanovic, A. Holmgren, B.P. Nelson, and L.I. Gordon Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family Br J Haematol 141 2008 676 680
39. M. Stewart, K. Talks, R. Leek, H. Turley, F. Pezzella, A. Harris, and K. Gatter Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma Histopathology 40 2002 253 260
40. S. Fruchon, S. Kheirallah, T. Al Saati, L. Ysebaert, C. Laurent, L. Leseux, J.J. Fournié, G. Laurent, and C. Bezombes Involvement of the Syk-mTOR pathway in follicular lymphoma cell invasion and angiogenesis Leukemia 26 2012 795 805
41. F. Pont, J. Familiades, S. Déjean, S. Fruchon, D. Cendron, M. Poupot, R. Poupot, F. L'faqihi-Olive, N. Prade, B. Ycart, and J.J. Fournié The gene expression profile of phosphoantigen-specific human γδ T lymphocytes is a blend of αβ T-cell and NK-cell signatures Eur J Immunol 42 2012 228 240
42. M.R. Green, M.K. Gandhi, M.J. Courtney, P. Marlton, and L. Griffiths Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NFkappaB activity in Follicular Lymphoma Leuk Res 33 2009 1699 1702
43. A.V. Kuznetsov, R. Margreiter, A. Amberger, V. Saks, and M. Grimm Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death Biochim Biophys Acta 1813 2011 1144 1152
44. L. Leseux, G. Laurent, C. Laurent, M. Rigo, A. Blanc, D. Olive, and C. Bezombes PKC zeta mTOR pathway: a new target for rituximab therapy in follicular lymphoma Blood 111 2008 285 291
45. A.G. Ramsay, A.J. Clear, G. Kelly, R. Fatah, J. Matthews, F. Macdougall, T.A. Lister, A.M. Lee, M. Calaminici, and J.G. Gribben Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy Blood 114 2009 4713 4720